EN | TR
E-ISSN: 3061-9947
The Prognostic Factors in Endometrial Cancers Treated with Radiotherapy: Retrospective Analysis
PDF
Cite
Share
Request
Original Article
VOLUME: 56 ISSUE: 3
P: 190-197
2023

The Prognostic Factors in Endometrial Cancers Treated with Radiotherapy: Retrospective Analysis

Acta Haematol Oncol Turc 2023;56(3):190-197
DOI: 10.5505/aot.2023.02779
Abdurahman Kuzhan 1
1. Pamukkale University, Medical School, Department Of Radiation Oncology,
2.
No information available.
No information available
Received Date: 2023-01-26T12:27:53
Accepted Date: 2023-12-04T07:22:37
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Endometrial cancer is mostly diagnosed in the early stages and has a good prognosis. Surgery has main role in the treatment of patients with endometrial cancer and adjuvant radiotherapy (RT) is administered in certain risk groups. In this retrospective study, we analyzed the factors affecting the prognosis of patients with endometrial cancer who underwent RT.

METHODS

A total of 181 patients who were diagnosed with endometrial cancer were included in the study. Based on the prognostic factors, risk groups were recorded as low, intermediate, high-intermediate, high risk, and advanced/metastatic. Patients’ overall survival (OS) was calculated using Kaplan– Meier method.

RESULTS

Median age was 60 years (28–82). The number of patients who received adjuvant RT alone, RT and chemotherapy, and chemotherapy alone were 77 (42.5%), 65 (36%), and 39 (21.5%), respectively. Median OS was 12.4 (range, 0.1-21) years. Except for the advanced/metastatic risk group, OS was better in all the other risk groups who received RT alone (p<0.001).

DISCUSSION AND CONCLUSION

Risk groups (based on prognostic risk factors), p53, and treatment applied (RT alone) are the significant prognostic indicators for patients received adjuvant therapy in endometrial cancer. Adding adjuvant chemotherapy to RT adversely affects the prognosis.